Ocular Therapeutix, Inc. - Common Stock (OCUL)

Detailed Quote

Previous Close	7.730
Open	7.650
Bid	7.170
Ask	7.200
Day's Range	7.120 - 7.840
52 Week Range	4.790 - 11.78
Volume	1,903,357
Market Cap	1.13B
PE Ratio (TTM)	-6.294
EPS (TTM)	-1.1
Dividend & Yield	N/A (N/A)
1 Month Average Volume	1,693,507

About Ocular Therapeutix, Inc. - Common Stock (OCUL)

Ocular Therapeutics is a biotechnology company focused on developing innovative therapies for eye diseases and conditions. The company is primarily engaged in the research and development of unique drug delivery solutions that aim to improve the effectiveness and safety of treatments for various ocular diseases. Ocular Therapeutics leverages advanced technology platforms to create products that can provide sustained release of medication, enhancing patient compliance and outcomes. Their pipeline includes therapies targeting conditions such as retinal diseases and dry eye, positioning the company at the forefront of addressing significant unmet needs in the field of ophthalmology.